Sign in →

Browse by Name

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #
 

Mayo Clinic Laboratories

Epic Test Code LAB3225 Cutaneous Immunofluorescence Antibodies, IgG and IgG4, Serum

Additional Codes

MML Code: CIFS

 

NY State Approved

Yes

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Reporting Name

Cutaneous Immfluor. Ab, IgG/IgG4, S

Method Name

Indirect Immunofluorescence Assay (IFA)

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 14 days
  Frozen  30 days
  Ambient  14 days


Specimen Required


Collection Container/Tube:

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 2 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Bassett Healthcare Network Clinical Laboratories Note:

Blood Tube Draw Volume
Min 50% draw volume  

Specimen Type

Serum

Specimen Minimum Volume

0.5 mL

Reference Values

Negative in normal individuals

Report Available

2 to 7 days

Day(s) Performed

Monday through Friday

CPT Code Information

88346

88350

88350 (if appropriate)

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Useful For

Confirming the presence of IgG and/or IgG4 antibodies to diagnose pemphigoid, pemphigus, epidermolysis bullosa acquisita, or bullous lupus erythematosus

Clinical Information

Immunoglobulin G (IgG) and/or IgG4 anti-basement membrane zone (BMZ) antibodies are produced by patients with pemphigoid, pemphigus, and other rare autoimmune blistering disorders such as epidermolysis bullosa acquisita and bullous lupus erythematosus. In most patients with bullous pemphigoid, serum contains IgG anti-BMZ antibodies, while in cicatricial pemphigoid circulating IgG anti-BMZ antibodies are found in a minority of cases.

 

Circulating IgG4 is also variably present. Sensitivity of detection of anti-BMZ antibodies is increased when serum is tested using both sodium chloride-split primate skin and primate esophagus as substrates and using both IgG and IgG4 reactants.

Interpretation

Indirect immunofluorescence (IF) testing may aid in the diagnosis of these conditions when correlated with histopathologic, direct immunofluorescence, and clinical information.

 

Anti-basement membrane zone (BMZ) antibodies correlate with a diagnosis of bullous pemphigoid, cicatricial pemphigoid, epidermolysis bullosa acquisita (EBA), or bullous eruption of lupus erythematosus (LE).

 

Anti-cell surface antibodies correlate with a diagnosis of pemphigus.

 

If serum contains anti-BMZ antibodies, the pattern of fluorescence on sodium chloride (NaCl)-split skin substrate helps distinguish pemphigoid from EBA and bullous LE. Staining of the roof (epidermal side) or both epidermal and dermal sides of NaCl-split skin correlates with the diagnosis of pemphigoid, while fluorescence localized only to the dermal side of the split-skin substrate correlates with either EBA or bullous LE.

 

The report includes presence and titer of circulating antibodies.

 

If the serum contains BMZ antibodies on the split-skin substrate, patterns will be reported as one of the following:

1. Epidermal pattern, suggestive of pemphigoid

2. Dermal pattern, suggestive of epidermolysis bullosa acquisita, bullous lupus erythematosus, or rare pemphigoid variants

3. Mixed pattern, suggestive of rare pemphigoid variants

 

If serum contains BMZ antibodies on the primate esophagus substrate, patterns will be reported as one of the following:

-BMZ (linear) pattern, suggestive of a subepidermal autoimmune mucocutaneous blistering disorder

-Intercellular substance (cell-surface) pattern, suggestive of pemphigus

Cautions

Results should be interpreted in conjunction with clinical information, histopathologic pattern, and results of direct immunofluorescence (DIF) study. In particular, the finding of low titer (≤1:80) antibodies should not be used alone (ie, without histopathologic or DIF support) to diagnose these conditions.

Specimen Retention Time

30 days

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
CIFST CIFS Titer, IgG, S No No

Testing Algorithm

If IgG anti-cell surface or anti-basement membrane zone antibodies are present, then the IgG antibody titer will be reflexed and performed at an additional charge.